• Filing Date: 2019-06-14
  • Form Type: 10-K
  • Description: Annual report
v3.19.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Revenues      
Total revenues $ 0 $ 0 $ 0
Operating expenses:      
Research and development 2,296,668 993,833 1,034,605
General and administrative 2,180,056 915,132 516,661
Total operating expenses 4,476,724 1,908,965 1,551,266
Loss from operations (4,476,724) (1,908,965) (1,551,266)
Interest income 23,927 88,516 0
Net loss (4,452,797) (1,820,449) (1,551,266)
Other comprehensive income/ (loss)      
Foreign currency translation adjustment, net of tax (299,263) 564,914 (760,999)
Comprehensive loss $ (4,752,060) $ (1,255,535) $ (2,312,265)
Loss per share      
Basic and diluted $ (0.02) $ (0.01) $ (0.00)
Weighted average number of common shares outstanding 180,903,839 150,070,400 205,000,000